We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

95 hedge funds and large institutions have $811M invested in Enfusion, Inc. in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,956% more call options, than puts

Call options by funds: $365K | Put options by funds: $9K

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

25% more funds holding

Funds holding: 7695 (+19)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

2% less capital invested

Capital invested by funds: $830M → $811M (-$19M)

Holders
95
Holders Change
+19
Holders Change %
+25%
% of All Funds
1.37%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
25
Increased
40
Reduced
18
Closed
6
Calls
$365K
Puts
$9K
Net Calls
+$356K
Net Calls Change
+$111K
Name Holding Trade Value Shares
Change
Change in
Stake
FMC
1
FTV Management Company
California
$300M
IC
2
Iconiq Capital
California
$130M
BCM
3
Brown Capital Management
Maryland
$92.3M -$16.2M -1,842,060 -16%
HA
4
HHLR Advisors
Cayman Islands
$46M
Vanguard Group
5
Vanguard Group
Pennsylvania
$33.8M +$455K +51,670 +1%
ACM
6
Ararat Capital Management
Connecticut
$28.3M +$4.16M +472,783 +18%
BlackRock
7
BlackRock
New York
$23.8M +$519K +58,994 +2%
1WCM
8
12 West Capital Management
New York
$17.6M
New York State Common Retirement Fund
9
New York State Common Retirement Fund
New York
$15M -$194 -22 -0%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$15M -$170K -19,303 -1%
NCM
11
Nellore Capital Management
California
$12.7M +$2.38M +270,543 +24%
T. Rowe Price Investment Management
12
T. Rowe Price Investment Management
Maryland
$8.14M +$34.1K +3,881 +0.4%
LECM
13
Lead Edge Capital Management
New York
$7.87M +$7.49M +850,967 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$7.54M +$311K +35,402 +5%
WA
15
Wasatch Advisors
Utah
$7.33M +$1.78M +201,771 +34%
State Street
16
State Street
Massachusetts
$6.99M +$564K +64,084 +9%
Bank of America
17
Bank of America
North Carolina
$6.9M +$3.01M +342,632 +85%
Wellington Management Group
18
Wellington Management Group
Massachusetts
$6.78M +$2.14M +243,700 +50%
Citadel Advisors
19
Citadel Advisors
Florida
$5.96M +$4.58M +520,403 +420%
SGM
20
Scalar Gauge Management
Texas
$4.66M +$2.62M +298,058 +145%
NCGI
21
Next Century Growth Investors
Minnesota
$4.32M +$838K +95,251 +26%
Northern Trust
22
Northern Trust
Illinois
$3.26M +$24K +2,731 +0.8%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$3.08M +$1.33M +151,362 +83%
Charles Schwab
24
Charles Schwab
California
$2.79M +$78.8K +8,957 +3%
CC
25
Clearline Capital
New York
$2.35M +$533K +60,556 +31%

ENFN Hedge Fund Activity: Q1 2024 in Review

95 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2024, worth a combined $811M — down 2.3% from $830M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ENFN positions and 6 closed out — a net gain of 19 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was Lead Edge Capital Management, opening a new position worth an estimated $7.49M. The largest seller was Brown Capital Management, cutting an estimated $16.2M.

  • 95 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $811M of Enfusion, Inc. stock for Q1 2024, down 2.3% quarter-over-quarter.
  • 25 funds opened new Enfusion, Inc. positions in Q1 2024 and 6 closed out, a net change of +19 holders.
  • The largest Enfusion, Inc. buyer in Q1 2024 was Lead Edge Capital Management, an estimated $7.49M added.
  • The largest Enfusion, Inc. seller in Q1 2024 was Brown Capital Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2024.